Topics/Sessions

  • Triggers for testing.
  • Overviews, case studies and discussion of current EDC tests and new assays under development.
  • Proposed testing schemes and gaps in relation to European regulatory schemes.
  • Provide scientific input into European regulatory proposals.
  • Perspectives from other regulatory bodies, including US, Canada, Japan.
  • Scientific recommendation of criteria to be applied in defining EDC’s.
  • Hazard vs risk based assessments, with case studies and use of weight of evidence.
  • Horizon scan of potential types of ED effects (e.g. in invertebrates) not yet considered for routine testing.
  • Read across from in vitro data and mammalian data to wildlife species.